article thumbnail

How health plans can leverage competitive intelligence data today to drive impact in 2024

Clarify Health

The strategic use of competitive intelligence data is increasingly becoming a crucial factor for healthcare payers looking to make informed decisions around strategic market expansion and strengthen their market position.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

In 2024, watch as the global trendsetter brings to bear its technological expertise combined with a captive Prime membership, brand recognition, and national employer buy-in to re-envision healthcare that truly works around the patient. Healthcare segment) across the nation as part of a $1 billion cost-cutting strategy.

Retail 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

Five IDNs to watch in 2023

Clarivate

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

article thumbnail

It’s Time We Got the Most Out of Medical Affairs Data

PM360

Without the imperative of immediate commercial outcomes, Field Medical Affairs also exists as a trusted relationship-builder in which medical science liaisons (MSLs) and healthcare providers (HCPs) can discuss treatment possibilities and scientific concerns candidly.

Medical 52
article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

It covers the product lifecycle in its entirety by delivering innovative approaches to anticipate and address the needs of patients, healthcare providers, and payers alike. By harnessing this wealth of information, companies gain a competitive edge, adapting swiftly to evolving market demands and stakeholder expectations.

Medical 52
article thumbnail

Five Good Reasons GoodRx Should Be in Your 2024 HCP Media Plan

PM360

Let’s get to the point: It’s time for pharma marketers and their media agencies to look beyond the “usual suspects” for new ways and new media partners to reliably deliver educational and promotional messages to healthcare providers (HCPs) specifically when they are in an action mindset.

Media 52